Загрузка...

CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy

OBJECTIVE: Third-generation aromatase inhibitors (AI) are potent suppressors of aromatase activity. The aim of this study was to measure the incidence of adverse effects in breast cancer patients treated with AI-based adjuvant therapy and the relationship with the CYP19A1 genotypes. MATERIALS AND ME...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eurasian J Med
Главные авторы: Mazzuca, Federica, Botticelli, Andrea, Mazzotti, Eva, La Torre, Marco, Borro, Marina, Marchetti, Luca, Maddalena, Chiara, Gentile, Giovanna, Simmaco, Maurizio, Marchetti, Paolo
Формат: Artigo
Язык:Inglês
Опубликовано: The Eurasian Journal of Medicine 2016
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792488/
https://ncbi.nlm.nih.gov/pubmed/27026757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurasianjmed.2015.008
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!